Literature DB >> 3308506

Plasmodium vivax: exoerythrocytic schizonts recognized by monoclonal antibodies against blood-stage schizonts.

S B Aley1, J W Barnwell, M D Bates, W E Collins, M R Hollingdale.   

Abstract

Exoerythrocytic parasites of Plasmodium vivax grown in human hepatoma cells in vitro were probed with monoclonal antibodies raised against other stages of P. vivax. Monoclonal antibodies specific for four independent antigens on blood-stage merozoites all reacted with exoerythrocytic schizonts and merozoites by immunostaining. The characteristic staining pattern of each monoclonal antibody was similar on both blood- and exoerythrocytic-stage parasites and appeared only in mature schizont segmenters. In contrast, a monoclonal antibody specific for the caveolar-vesicle complex of the infected host cell membrane and a second monoclonal antibody reacting with an unknown internal antigen did not appear to react with exoerythrocytic parasites. We confirm prior reports that monoclonal antibodies against the sporozoite immunodominant repeat antigen react with all exoerythrocytic-stage parasites, but note that as the exoerythrocytic parasite matures the immunostaining is concentrated in plaques reminiscent of germinal centers and apparently distinct from mature merozoites. These results indicate that mature merozoites from either exoerythrocytic or blood-stage parasites are antigenically very similar, but that stage-specific antigens may be found in specialized structures present only in a specific host cell type.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3308506     DOI: 10.1016/0014-4894(87)90142-1

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  6 in total

1.  Use of non-human primate hepatocytes for in vitro study of the pre-erythrocytic stages of malaria parasites.

Authors:  P Millet; W E Collins; M Aikawa; A H Cochrane; P Nguyen-Dinh
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii.

Authors:  Yuko Kawabata; Heiichiro Udono; Kiri Honma; Masakatsu Ueda; Hiroshi Mukae; Jun-Ichi Kadota; Shigeru Kohno; Katsuyuki Yui
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

3.  Induction of Multifunctional Broadly Reactive T Cell Responses by a Plasmodium vivax Circumsporozoite Protein Recombinant Chimera.

Authors:  Monica Cabrera-Mora; Jairo Andres Fonseca; Balwan Singh; Joseli Oliveira-Ferreira; Josué da Costa Lima-Junior; J Mauricio Calvo-Calle; Alberto Moreno
Journal:  Infect Immun       Date:  2015-07-13       Impact factor: 3.441

4.  Construction of a tetR-integrated Salmonella enterica serovar Typhi CVD908 strain that tightly controls expression of the major merozoite surface protein of Plasmodium falciparum for applications in human Vaccine production.

Authors:  Feng Qian; Weiqing Pan
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

5.  Establishment of an in vitro assay for assessing the effects of drugs on the liver stages of Plasmodium vivax malaria.

Authors:  Rana Chattopadhyay; Soundarapandian Velmurugan; Chinnamma Chakiath; Lucy Andrews Donkor; Wilbur Milhous; John W Barnwell; William E Collins; Stephen L Hoffman
Journal:  PLoS One       Date:  2010-12-09       Impact factor: 3.240

6.  Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge.

Authors:  L Rénia; I T Ling; M Marussig; F Miltgen; A A Holder; D Mazier
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.